Link to: Get in touch
Indicator 1
Presence of a PHC facility-based patient record system which includes NCD status
Definition
Presence of a PHC facility-based patient record system that includes NCD status:
- a.national
- b.subnational
- c.electronic
- d.paper-based
Presence or Absence
Present
Reference
Indicator 2
Existence of a facility-level information system that includes CVD risk assessment, Diabetes, and Hypertension care
Definition
Existence of a facility-level information system that includes CVD risk assessment, Diabetes, and Hypertension care
Presence or Absence
Present
Reference
- Basic Interventions of Non-Communicable Diseases in the Primary Health Care System of Iran (IraPEN): Behvarz Executive Instruction. (2017) Tehran. Mojasameh publication. (pages 8, 15, 18-19) [In Persian]
- Basic Interventions of Non-Communicable Diseases in the Primary Health Care System of Iran (IraPEN): Physician Executive Instruction. (2017) Tehran. Mojasameh publication. (pages 7-8) [In Persian]
- Health evolution Plan. Chapter 8 (pages: 573-5) [In Persian]
Indicator 3
Presence of regular national adult NCD risk factor surveillance, conducting assessments every 3 to 5 years (STEPS or other)
Definition
Presence of regular national adult NCD risk factor surveillance, conducting assessments every 3 to 5 years (STEPS or other)
Presence or Absence
Present
Reference
- Atlas of Non-Communicable Diseases Risk Factors Surveillance in the Islamic Republic of Iran – STEPs 2016 [English– Persian]
- STEPs archive is available at Iran National Institutes of Health (NIH)
Indicator 4
Existence of a PHC facility level register for patients with RF/RHD
Definition
Existence of a PHC facility level register for patients with RF/RHD
Presence or Absence
Present
Reference
- List of Iran disease registries
- Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. ISBN: 978-92-4-000231-9 [In English] (Page:57)
Indicator 5
Are the NCDs among the national list of notifiable diseases?
Presence or Absence
Present
Definition
Are the NCDs among the national list of notifiable diseases?
a. RHD
b. Cervical cancer
c. Colorectal cancer
d. Diabetes
Reference
- RHD
- Cancers:
National Program for Early Cancer Diagnosis in Iran (2021), Mirmah publishing. ISBN: 9786003334496
- Diabetes (Absent)
Indicator 6
Percentage of facilities that provide the % of HTN patients
Indicator
Percentage of facilities that provide the % of HTN patients
Presence or Absence
Present
Definition
Numerator: Number of facilities that able to provide
– % or number of registered HTN patients disaggregated by age
– % or number of registered HTN patients disaggregated by gender
– % or number of undertreatment among patients registered
– % or number of patients controlled among patients undertreatment
Denominator: Total number of facilities
Reference
- Facility survey
Raw Data
Numerator | Denumerator | Percent | ||
Total | Disaggregated by age | 5991 | 5991 | 100% |
Disaggregated by gender | 5991 | 5991 | 100% | |
Disaggregated by treatment status | 5991 | 5991 | 100% | |
Disaggregated by control status | 5991 | 5991 | 100% | |
Urban | Disaggregated by age | 3202 | 3202 | 100% |
Disaggregated by gender | 3202 | 3202 | 100% | |
Disaggregated by treatment status | 3202 | 3202 | 100% | |
Disaggregated by control status | 3202 | 3202 | 100% | |
Rural | Disaggregated by age | 2789 | 2789 | 100% |
Disaggregated by gender | 2789 | 2789 | 100% | |
Disaggregated by treatment status | 2789 | 2789 | 100% | |
Disaggregated by control status | 2789 | 2789 | 100% |
Indicator 7
Percentage of facilities that provide the % of diabetic patients
Indicator
Percentage of facilities that provide the % of diabetic patients
Presence or Absence
Present
Definition
Numerator: Number of facilities that able to provide:
– % or number of registered Diabetes patients disaggregated by age
– % or number of registered Diabetes patients disaggregated by gender
– % or number of undertreatment among patients registered
– % or number of patients controlled among patients undertreatment
Denominator: Total number of facilities
Reference
- Facility survey
Raw Data
Numerator | Denumerator | Percent | ||
Total | Disaggregated by age | 5991 | 5991 | 100% |
Disaggregated by gender | 5991 | 5991 | 100% | |
Disaggregated by treatment status | 5991 | 5991 | 100% | |
Disaggregated by control status | 5991 | 5991 | 100% | |
Urban | Disaggregated by age | 3202 | 3202 | 100% |
Disaggregated by gender | 3202 | 3202 | 100% | |
Disaggregated by treatment status | 3202 | 3202 | 100% | |
Disaggregated by control status | 3202 | 3202 | 100% | |
Rural | Disaggregated by age | 2789 | 2789 | 100% |
Disaggregated by gender | 2789 | 2789 | 100% | |
Disaggregated by treatment status | 2789 | 2789 | 100% | |
Disaggregated by control status | 2789 | 2789 | 100% |
Indicator 8
Percentage of facilities that provide the % of cancer patients
Indicator
Percentage of facilities that provide the % of cancer patients
Presence or Absence
Present
Definition
Numerator: Number of facilities that able to provide:
– % or number of registered cancer patients disaggregated by Type of cancer
– % or number of registered cancer patients disaggregated by age
– % or number of registered cancer patients disaggregated by gender
– % or number of undertreatment among patients registered
– % or number of patients controlled among patients undertreatment
Denominator: Total number of facilities
Reference
- Facility survey
Raw Data
Numerator | Denumerator | Percent | ||
Total | Disaggregated by type of cancer | 755 | 5991 | 13% |
Disaggregated by age | 755 | 5991 | 13% | |
Disaggregated by gender | 755 | 5991 | 13% | |
Disaggregated by treatment status | 755 | 5991 | 13% | |
Disaggregated by control status | 473 | 5991 | 8% |
Indicator 9
Percentage of facilities that provide the % of patients with chronic respiratory diseases
Indicator
Percentage of facilities that provide the % of patients with chronic respiratory diseases
Presence or Absence
Present
Definition
Numerator: Number of facilities that able to provide:
– % or number of registered COPD patients disaggregated by Type of COPD
– % or number of registered COPD patients disaggregated by age
– % or number of registered COPD patients disaggregated by gender
– % or number of undertreatment among patients registered
– % or number of patients controlled among patients undertreatment
Denominator: Total number of facilities
Reference
- Facility survey
Raw Data
Numerator | Denumerator | Percent | ||
Total | Disaggregated by type of COPD | 356 | 5991 | 6% |
Disaggregated by age | 356 | 5991 | 6% | |
Disaggregated by gender | 356 | 5991 | 6% | |
Disaggregated by treatment status | 356 | 5991 | 6% | |
Disaggregated by control status | 74 | 5991 | 1% |
Indicator 10
% of NCD patients with regular follow-ups
Indicator
% of NCD patients with regular follow-ups
Presence or Absence
Absent
Definition
Numerator: Number of NCD patients with regular follow up
Denominator: Total number of NCD patients
Reference
- No data
Indicator 11
Estimation of populations at risk identified through surveys
Definition
Estimation of populations at risk identified through surveys:
a. CVD risk
b. Pre- Diabetes
Presence or Absence
Present
Reference
- Atlas of Non-Communicable Diseases Risk Factors Surveillance in the Islamic Republic of Iran – STEPs 2016 [English– Persian]
- Zadnajafabad, S., Mohammadi, E., Aminorroaya, A. et al. Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-020-00709-8
Indicator 12
Register of NCD complications exist at PHC facility level
Definition
Register of NCD complications exist at PHC facility level
a.DKA
b.Hypoglycemic admission
c.renal failure
d.retinopathy
e.diabetic ulcer
Presence or Absence
Present
Reference
Indicator 13
Assessment of availability and affordability of NCD medicines in the Public/Private sector
Definition
Assessment of availability and affordability of NCD medicines in Public/Private sector
Presence or Absence
Present
Reference
- Heidari E; Varmaghani M; Abdollahiasl A. Availability, pricing, and affordability of selected medicines for noncommunicable diseases. East Mediterr Health J. 2019;25(7):473-480. https://doi.org/10.26719/emhj.18.068